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Differential Effects of CpG DNA on IFN- Induction and
STAT1 Activation in Murine Macrophages versus Dendritic
Cells: Alternatively Activated STAT1 Negatively Regulates
TLR Signaling in Macrophages1
Kate Schroder,* Martina Spille,† Andreas Pilz,‡ Jane Lattin,* Konrad A. Bode,†
Katharine M. Irvine,* Allan D. Burrows,* Timothy Ravasi,§ Heike Weighardt,¶
Katryn J. Stacey,* Thomas Decker,‡ David A. Hume,* Alexander H. Dalpke,†
and Matthew J. Sweet2*
Classical STAT1 activation in response to TLR agonists occurs by phosphorylation of the Y701 and S727 residues through
autocrine type I IFN signaling and p38 MAPK signaling, respectively. In this study, we report that the TLR9 agonist CpG DNA
induced Ifn- mRNA, as well as downstream type I IFN-dependent genes, in a MyD88-dependent manner in mouse myeloid
dendritic cells. This pathway was required for maximal TNF and IL-6 secretion, as well as expression of cell surface costimulatory
molecules. By contrast, neither A- nor B-type CpG-containing oligonucleotides induced Ifn- in mouse bone marrow-derived
macrophages (BMM) and a CpG-B oligonucleotide did not induce IFn- in the macrophage-like cell line, J774. In BMM, STAT1
was alternatively activated (phosphorylated on S727, but not Y701), and was retained in the cytoplasm in response to CpG DNA.
CpG DNA responses were altered in BMM from STAT1S727A mice; Il-12p40 and Cox-2 mRNAs were more highly induced,
whereas Tlr4 and Tlr9 mRNAs were more repressed. The data suggest a novel inhibitory function for cytoplasmic STAT1 in
response to TLR agonists that activate p38 MAPK but do not elicit type I IFN production. Indeed, the TLR7 agonist, R837, failed
to induce Ifn- mRNA and consequently triggered STAT1 phosphorylation on S727, but not Y701, in human monocyte-derived
macrophages. The differential activation of Ifn- and STAT1 by CpG DNA in mouse macrophages vs dendritic cells provides a
likely mechanism for their divergent roles in priming the adaptive immune response. The Journal of Immunology, 2007, 179:
3495–3503.
A ctivation of innate immune cells such as macrophagesand dendritic cells (DC)3 commonly involves concertedsignaling by cytokines such as IFNs, and microbial
products such as LPS and CpG DNA (1). Many cytokines act
through members of the hemopoietin receptor family, and their
actions are coupled to the JAK-STAT signaling cascade. Microbial
products act through the TLR family, which are coupled via adap-
tor proteins such as MyD88 to downstream effectors such as NF-
B. IFNs prime for maximal activation in response to the TLR
agonists LPS and CpG DNA, and the IFN-responsive STAT fam-
ily member STAT1 can integrate the two pathways; IFNs and LPS
both induce STAT1 phosphorylation and STAT1-dependent gene
expression (1, 2).
TLRs differ in the use of specific adaptors and consequent in-
duction of target genes. The response to LPS requires TLR4 (3),
which signals through both MyD88-independent (mediated by the
TIR domain-containing adaptor proteins 1 and 2 and MyD88-de-
pendent pathways (reviewed in Ref. 4). By contrast, CpG DNA-
dependent signaling via TLR9 absolutely requires MyD88 (5).
Consequently, LPS, but not CpG DNA, induces a set of MyD88-
independent genes in macrophages (6, 7). One of the MyD88-
independent genes induced by LPS in macrophages encodes the
type I IFN, IFN- (8, 9). LPS-induced IFN- acts in an autocrine
fashion to activate tyrosine phosphorylation of STAT1, which in
turn induces a set of target genes, including inducible NO syn-
thetase in macrophages (9, 10).
TLR signaling also modifies STAT1 more directly through
phosphorylation at S727 (11, 12), which occurs via a p38 MAPK-
dependent pathway (13–15). The contributions of S727 phosphor-
ylation to the actions of STAT1 were analyzed using STAT1S727A
mutant mice, in which an alanine is substituted for the serine at
residue 727 of STAT1 (12). These mice were resistant to LPS
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shock, and macrophages from these mice were less sensitive to the
combined effects of IFN- plus LPS in vitro (12). Phosphorylation
of STAT1 on Y701 is required for homo- and heterodimerization
and for nuclear translocation and transcriptional activation. Nev-
ertheless, STAT1 phosphorylated at S727, but not Y701, can still
regulate gene expression (16–20). STAT1 serine phosphorylation
was required, whereas tyrosine phosphorylation and homodimer-
ization were dispensable, for maximal constitutive expression of
caspase-2 and -3 in fibroblasts (16). Furthermore, Y701 mutants of
STAT1 still regulated the constitutive expression of several genes,
including CycA, Hsp70, and Lmp2, in fibroblasts (17).
Early studies on CpG DNA signaling in macrophages implied
that this stimulus did not elicit type I IFN production (21, 22),
consistent with the inability of CpG DNA to activate MyD88-
independent signaling pathways (5). However, recent reports dem-
onstrated that CpG DNA triggered IFN- production in myeloid
DC in a MyD88-dependent fashion via IFN regulatory factor
(IRF)1 (23, 24). In addition, in plasmacytoid DC (pDC), endoso-
mal retention of CpG DNA enabled MyD88-dependent activation
of the IRF family member, IRF7, leading to type I IFN production
(25, 26). CpG-containing oligonucleotides that effectively induce
type I IFN in pDC are termed A type and have a palindromic
central CpG motif, which can form a double-stranded region, and
strings of G residues at both the 3 and 5 ends. A-type and con-
ventional single-stranded B-type CpG-containing oligonucleotides
traffic differentially in pDC; A-type oligonucleotides are retained
in early endosome-like structures and initiate signaling leading to
type I IFN production, whereas B-type oligonucleotides traffic to a
late endosome/lysosome compartment and more strongly induce
inflammatory cytokines, such as TNF (26). Differences between
macrophages and DC in their response to MyD88-dependent sig-
nals could be important in constraining pathological consequences
of macrophage activation (e.g., septic shock), while permitting ac-
tivation of acquired immunity.
In this study, we confirm that macrophages differ from DC in
their response to MyD88-dependent signaling by CpG DNA. The
MyD88-dependent production of IFN- was essential for CpG
DNA-mediated DC maturation, and provides an important insight
into the powerful adjuvant activity of CpG DNA. Conversely, the
failure of macrophages to respond to CpG DNA with inducible
IFN- expression reveals a novel cytoplasmic function for STAT1,
which limits the production of a subset of inflammatory mediators.
We propose that the divergent responses of macrophages and DC
to CpG DNA could derive from differential expression of members
of the IRF family.
Materials and Methods
General reagents
Recombinant mouse IFN- (R&D Systems) and IFN- (PBL) were used at
a final concentration of 500 pg/ml and 100 U/ml, respectively. LPS (from
Salmonella minnesota; Sigma-Aldrich) was used at a final concentration of
10 ng/ml, unless otherwise stated. Lipoteichoic acid (LTA) from Staphy-
lococcus aureus was a gift from S. Morath (Konstanz, Germany);
PAM3CSK4 was obtained from EMC Microcollections. R837 (imi-
quimod), a specific TLR7 agonist (27, 28), was purchased from InvivoGen.
Human rCSF-1 (a gift from Chiron) was used at a final concentration of
1  104 U/ml (100 ng/ml). Unless otherwise stated, the well-characterized
B-type phosphorothioate-modified oligonucleotide 1668S (5-tccatgacgttc-
ctgatgct-3) (29) was used in all experiments at a final concentration of 0.1
M. The GC inversion of this oligonucleotide, 1668S-GC, 5-tccatgagct-
tcctgatgct-3, was used to control for CpG DNA-independent effects on
cells (29). In experiments in which A-type oligos were examined, the D19
oligonucleotide (5-ggTGCATCGATGCAgggggG-3) (26) and the 1585
oligonucleotide (5-ggGGTCAACGTTGAgggggG-3) (30) were used. Up-
per and lower case letters indicate bases with phosphodiester- and phos-
phorothioate-modified linkages, respectively. All oligonucleotides were
synthesized by Geneworks. Abs used in Western blotting were purchased
from Cell Signaling Technology (anti-STAT1, anti-phospho-Y701-STAT1,
anti-p38 MAPK, anti-phospho-p38 MAPK, anti-ERK-1/2, anti-phospho-ERK-
1/2, anti-CSF-1R, goat anti-rabbit IgG), Calbiochem (anti-phospho-S727-
STAT1), or Santa Cruz Biotechnology (anti-PU.1). All primary Abs were
used at 1:1000, except anti-PU.1, which was used at 1:5000, whereas the
secondary Ab was used at 1:3000.
Preparation of macrophages and DC
Bone marrow-derived macrophages (BMM) were obtained by ex vivo dif-
ferentiation from mouse bone marrow progenitors in the presence of
rCSF-1 over 7 days, as described previously (31, 32). C57BL/6 male mice
(6–8 wk old) kept under specific pathogen-free conditions were used in
BMM generation. For experiments with wild-type (WT) vs STAT1S727A
mice, bone marrow progenitors were pooled from equal numbers of age-
matched male and female mice in each experiment. J774 macrophages
(American Type Culture Collection) were maintained in RPMI 1640 sup-
plemented with 5% FCS and antibiotics (100 IU/ml penicillin G and 100
IU/ml streptomycin sulfate). GM-CSF-derived (CD11c, B220) bone
marrow-derived DC (BMDC) were prepared, as described previously (33),
from C57BL/6 female 6- to 8-wk-old mice. Where the effect of IFNAR1 or
MyD88 genotype was examined, SV129 IFNAR1/, SV129 IFNAR1/,
BALB/c MyD88/, or BALB/c MyD88/ mice were used as a source of
DC and BMM. All experiments with mouse primary cells were conducted
in accordance with local animal ethics guidelines.
Human macrophages were derived from monocytes isolated from blood
donations obtained from the Australian Red Cross Blood Bank. PBMC
were separated from buffy coat by Ficoll-Paque (Amersham) density cen-
trifugation. CD14 monocytes were isolated from the PBMC by positive
selection for CD14 using MACS magnetic beads (Miltenyi Biotec), ac-
cording to the manufacturer’s instructions. Monocytes were seeded on tis-
sue culture plastic at 15  106 per plate in IMDM (Invitrogen Life Tech-
nologies) with 10% FCS, CSF-1, and antibiotics, as above, and allowed to
differentiate into macrophages for 6 days. Macrophages were supple-
mented with CSF-1-replete medium on day 5, and both the adherent and
nonadherent cells were reseeded on day 6 and harvested for analysis on
day 7.
Determination of mRNA expression by quantitative PCR
(qPCR)
Cellular RNA was extracted using RNeasy kits (Qiagen) or HighPure RNA
kits (Roche). Contaminating genomic DNA was removed using DNA-Free
(Ambion), and cDNA was synthesized using Superscript III (Invitrogen
Life Technologies) or reverse transcriptase (MBI Fermentas) and oligo(dT)
primer. Negative control reactions were performed as above, with the
omission of the enzyme. cDNA was quantitated using the Platinum SYBR
Green quantitative PCR system (Invitrogen Life Technologies) or TaqMan
reagents (AbGene) and fluorogenic probes (FAM/TAMRA; Eurogentec).
Negative control reactions were cycled alongside test samples to ensure the
absence of contaminating genomic DNA. Data were analyzed using ABI
Prism software. Expression was determined relative to the abundance of
housekeeping genes (SYBR Green, hypoxanthine guanine phosphoribosyl-
transferase Hprt; TaqMan, -actin). Transcript abundance (Gene/Hprt or
Gene/-actin) and SD were determined, as recommended by Applied Bio-
systems. Where inducible expression in cells of different genotypes was
compared, expression was determined as a fold induction relative to basal
expression within the genotype. Profiles were quantitated in at least three
separate experiments using completely independent preparations of cells
and RNA extracts, unless otherwise stated. Real-time PCR primer pairs
were designed and tested as described previously (34). Primer sequences
are available on request.
ELISA
The levels of secreted cytokines (IFN--inducible protein-10 (IP-10), TNF,
and IL-6) in culture supernatants were determined using ELISA kits
(OptEiA; BD Biosciences).
Flow cytometry
Cell surface proteins were stained using anti-CD80 and anti-CD86 Abs
(BD Biosciences) and analyzed by flow cytometry using a FACS Canto
(BD Biosciences).
Immunoblot analysis
Western analysis of phospho-specific protein forms included phosphatase
inhibitors (1 mM sodium vanadate, 1 mM sodium pyrophosphate, 1 mM
sodium molybdate, 10 mM sodium fluoride) in all steps of protein extract
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preparation and immunodetection. The fractionation of nuclear and ex-
tranuclear proteins was performed at 4°C, and all solutions for extract
preparation were prechilled and included 5 M PMSF and 1 protease
inhibitors (Roche). Cells were harvested and washed twice with PBS. The
cell pellet was resuspended in 225 l of plasma membrane lysis buffer (10
mM HEPES (pH 7.4), 1.5 mM MgCl2, 10 mM KCl, 0.1% Nonidet P-40)
per 10  106 cells, and incubated for 5 min. Nuclei were separated from
the solubilized extranuclear extract by centrifugation, and the nuclei were
washed three times with plasma membrane lysis buffer. Nuclei were re-
suspended in 75 l of nuclei lysis buffer (20 mM HEPES (pH 7.8), 420
mM NaCl, 20% glycerol, 0.2 mM EDTA, 1.5 mM MgCl2) per 10  106
cells and incubated for 10 min. The nuclear extract was clarified by cen-
trifugation. Total protein in whole cell, nuclear, and extranuclear extracts
was quantitated using the BCA Protein Assay Kit (Pierce) to normalize
total protein loading. Whole cell extracts were prepared by boiling lysis
(35), and whole cell and fractionated extracts were analyzed by Western
blot, as described previously (35, 36).
Results
CpG DNA induces type I IFN and downstream target genes via
MyD88 in mouse DC, but not macrophages
CpG DNA did not induce IFN- expression in mouse bone mar-
row-derived macrophages (BMM) or RAW264.7 cells (26), but
recent studies have identified a MyD88-dependent pathway lead-
ing to Ifn- production in BMDC (8, 23, 24). Fig. 1 shows a direct
comparison of the effects of the B-type CpG DNA, 1668S, on
mouse macrophages and DC. CpG DNA strongly induced Ifn-
FIGURE 1. CpG DNA induces
Ifn- and IFN--dependent gene ex-
pression in BMDC, but not macro-
phages. BMDC (A and B), J774 cells
(C and D), and BMM (E) were stim-
ulated with varying doses of CpG
DNA or LPS for 3 h. Experiments
with BMM also included stimulation
with 5 g/ml PAM3CSK4 (P3C) or
10 g/ml LTA. Total cellular RNA
was prepared, and the mRNA expres-
sion of Ifn- (A, C, and E) and Ip-10
(B and D), relative to -actin (A–E)
was determined by qPCR. Data points
represent the average of duplicates 
SD. Profiles are representative of two
independent experiments. F and G,
BMM were stimulated with CpG
DNA (0.1 M) or LPS (10 ng/ml)
over a time course (F and G). Total
cellular RNA was prepared, and
mRNA expression of Ifn- (F) and Il-
12p40 (G) relative to Hprt was deter-
mined by qPCR. H–J, BMM were
stimulated with 0.1 M or 1 M A-
type CpG DNA (D19, 1585), B-type
CpG DNA (1668S, 0.1 M), or LPS
(10 ng/ml) for 2 h. Total cellular
RNA was prepared, and mRNA ex-
pression of Ifn- (H), Ip-10 (I), and
Tnf (J) relative to Hprt was deter-
mined by qPCR. Data points repre-
sent the average of triplicates  SD.
Profiles are representative of at least
three independent experiments.
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mRNA expression (Fig. 1A), as well as expression of the type I
IFN target gene, Ip-10 (Fig. 1B) in BMDC. In contrast, the mouse
macrophage cell line J774 responded to LPS, but not CpG DNA,
with inducible Ifn- mRNA expression (Fig. 1C), as well as down-
stream responses such as induction of Ip-10 mRNA (Fig. 1D) and
protein (data not shown). The responsiveness of J774 cells to both
stimuli was confirmed by assessing Tnf mRNA expression (data
not shown). Similarly, stimulation of BMM with LPS, but not CpG
DNA, for 3 h elicited robust Ifn- mRNA expression (Fig. 1E). In
these cells, the TLR2 ligands, Pam3CSK4 and LTA, were also
ineffective at inducing Ifn- gene expression (Fig. 1E). Even after
prolonged incubation with CpG DNA, there was no induction of
Ifn- (Fig. 1F), whereas Il-12p40 (Fig. 1G) and Tnf (data not
shown) were highly induced.
Distinct classes of CpG-containing oligonucleotides vary in
their capacity to elicit type I IFN production. In pDC, A-type oli-
gonucleotides such as D19 and 1585 are a more potent stimulus for
Ifn- expression than B-type oligonucleotides (26, 37). In BMM,
however, neither A-type nor B-type oligonucleotides induced ro-
bust Ifn- expression (Fig. 1H) or expression of the IFN- target
gene Ip-10 (Fig. 1I). The activity of A-type oligonucleotides was
confirmed by assessing Tnf expression (Fig. 1J). Because the na-
ture of the CpG DNA did not affect Ifn- induction and the B-type
oligonucleotide was a more potent activator of macrophage func-
tion (Fig. 1J), the B-type CpG DNA 1668S was used for all further
studies.
The response to CpG DNA and other TLR agonists is dependent
upon the adaptor protein MyD88. Although LPS elicited IP-10
production in both BMM (Fig. 2A) and BMDC (Fig. 2C) from
MyD88-deficient mice, production of IP-10 in response to CpG
DNA was absolutely dependent on MyD88 in BMDC. As ex-
pected, TNF production from both BMM (Fig. 2B) and BMDC
(Fig. 2D) was either partially dependent (LPS) or totally dependent
(CpG DNA) on MyD88. Hence, CpG DNA-triggered IFN- pro-
duction in the myeloid DC lineage is MyD88 dependent. By ex-
tension, because macrophages can respond to CpG DNA (and
TLR2 agonists) in a MyD88-dependent manner, the signaling
blockade in these cells lies specifically within the pathways linking
MyD88 to IFN- production.
The type I IFN pathway is required for both cytokine production
and cell surface costimulatory molecule expression in response
to CpG DNA in BMDC
Autocrine actions of CpG DNA-induced IFN- have not been
widely implicated in DC maturation. We assessed the phenotype
of BMDC derived from mice in which the IFN- receptor is
nonfunctional due to targeted deletion of the receptor subunit
IFNAR1. As expected, induction of Ip-10 mRNA by LPS and CpG
DNA was impaired in BMDC from IFNAR1-deficient animals
(Fig. 3A). CpG DNA- and LPS-mediated up-regulation of surface
expression of the costimulatory molecules CD80 (Fig. 3B) and
CD86 (Fig. 3C), as well as production of both TNF (Fig. 3D) and
IL-6 (Fig. 3E), was also dependent on type I IFN signaling. How-
ever, this pathway did not play a major role in the response to
Pam3Cys (Fig. 3, D and E).
The Tnf and Il-6 genes are classically regarded as primary re-
sponse genes in TLR signaling. Because CpG DNA induced Ifn-
mRNA expression in BMDC, but not macrophages (Fig. 1), we
predicted that exogenous IFN- would enhance TNF and IL-6 pro-
duction in response to CpG DNA in macrophages, but not DC.
This was indeed the case (Fig. 3, F–I). As expected, IFN- did not
amplify BMM (Fig. 3, F and G) or BMDC (Fig. 3, H and I) re-
sponses to LPS, because this agonist induced Ifn- mRNA expres-
sion in both cell types (Fig. 1). Thus, autocrine IFN- allows DC,
but not macrophages, to elicit maximal cytokine production and
costimulatory molecule expression in response to CpG DNA.
CpG DNA activates serine, but not tyrosine, phosphorylation of
STAT1 in BMM
TLR agonists activate STAT1 phosphorylation on S727 via a p38-
dependent pathway (13). Since IFN- was not produced in re-
sponse to CpG DNA in macrophages (Fig. 1), CpG DNA induced
an alternative STAT1 activation state in which S727, but not
Y701, was phosphorylated in BMM (Fig. 4A). In contrast, both
LPS (Fig. 4B) and IFN- (Fig. 4C) triggered dual Y701/S727
phosphorylation of STAT1 in BMM, as previously reported (38–
40). The time course of Y701 phosphorylation in response to LPS
was delayed, reflecting the autocrine nature of IFN- signaling.
FIGURE 2. CpG DNA-induced
IFN--dependent gene expression in
BMDC is dependent on MyD88. BMM
(A and B) and BMDC (C and D) de-
rived from WT () or MyD88 knock-
out mice (f) were stimulated with
varying doses of CpG DNA or LPS
overnight. Culture supernatants were
assayed for secretion of IP-10 (A and C)
and TNF (B and D) by ELISA. Data
points represent the average of tripli-
cates  SD. Profiles are representative
of two independent experiments.
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STAT1 homo- and heterodimerization are mediated by phos-
phorylation of Y701 at the C-terminal end of the STAT1 Src ho-
mology 2 domain (41). Fig. 5 shows that STAT1 translocated to
the nucleus during classical activation (Y701, S727 diphosphory-
lation) by LPS or IFN-, but was retained in the cytoplasm fol-
lowing alternative activation (monophosphorylation at S727) by
CpG DNA. The integrity of the nuclear and extranuclear extracts
used in this analysis was confirmed by immunoblotting for PU.1 (a
nuclear transcription factor) and the exclusively extranuclear pro-
tein, CSF-1R (a plasma membrane receptor). Total STAT1 levels
served as an internal control within the experiment. We and others
showed that LPS and CpG DNA caused a loss of cell surface
CSF-1R due to cleavage of the extracellular domain, whereas
IFN- only modestly down-regulated cell surface CSF-1R expres-
sion (34, 36, 42, 43). Consistent with these previous findings,
FIGURE 3. CpG DNA-induced cytokine production and induction of costimulatory molecules are dependent on type I IFN in BMDC. BMDC derived
from WT () or IFNAR1 knockout mice (f) were stimulated with 1 M CpG DNA or 100 ng/ml LPS in matched samples over a 24-h time course. Total
cellular RNA was prepared, and mRNA expression of Ip-10 (A) relative to -actin was determined by qPCR. Data points represent the average of duplicates 
SD. Profiles are representative of at least two independent experiments. WT or IFNAR1 BMDC were stimulated with 1 M CpG DNA or 100 ng/ml LPS
for 20 h. Surface expression of CD80 (B) and CD86 (C) was analyzed by FACS. Data points represent the average of three quantitations using cells derived
from separate mice  SD. Profiles are representative of three independent experiments. WT or IFNAR1 knockout BMDC (D and E), J774 macrophages
(F and G), or BMDC (H and I) were stimulated with varying doses of CpG DNA or LPS overnight, in the presence or absence of 100 U/ml IFN- (F–I).
Culture supernatants were harvested and assayed for TNF (D, F, and H) and IL-6 (E, G, and I) secretion by ELISA. Data points represent the average of
duplicate quantitations  SD. Profiles are representative of three independent experiments.
FIGURE 4. CpG DNA triggers S727, but not Y701, STAT1 phosphor-
ylation in BMM. BMM were treated with A, CpG DNA or the GC inver-
sion of the CpG DNA oligonucleotide (GC, for 1 h) to control for CpG
DNA-independent effects; B, LPS; or C, IFN- over a time course. Phos-
pho-S727 STAT1 (p-S727), phospho-Y701 STAT1 (p-Y701), and total
STAT1 in whole cell extracts were detected by immunoblotting. A positive
control (con, 0.5-h IFN- stimulation) was included for the detection of
phospho-Y701 STAT1 on blots containing CpG DNA time courses. Pro-
files are indicative of at least three independent experiments.
FIGURE 5. S727-phosphorylated STAT1 is retained in the cytoplasm
following CpG DNA stimulation. BMM were treated with CpG DNA,
LPS, or IFN-, and the cellular localization of STAT1 was monitored. The
nuclear and extranuclear compartments were fractionated, and levels of
phospho-S727 STAT1 (p-S727), phospho-Y701 STAT1 (p-Y701), total
STAT1, PU.1, and CSF-1R in the nuclear and extranuclear cell extracts
were detected by immunoblotting. Phospho-STAT1, total STAT1, and
PU.1 profiles are representative of at least two independent experiments.
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CSF-1R levels in extranuclear extracts were markedly reduced in
response to LPS and CpG DNA, but were only modestly affected
by IFN- (Fig. 5), thus confirming the activity of all stimuli used.
Hence, BMM responding to CpG DNA provide a model system in
which the function of S727 phosphorylation can be examined in
isolation.
Alternatively activated STAT1 regulates gene expression in
response to CpG DNA in BMM
The function of STAT1 S727 phosphorylation in the CpG DNA
response was examined using mice in which the S727 residue was
replaced with an alanine (STAT1S727A mice) (12). BMM from
these mice showed a selective defect in serine phosphorylation in
response to CpG DNA or IFN-, whereas IFN--dependent Y701
phosphorylation was intact (Fig. 6A). STAT1-independent signal-
ing by CpG DNA was unaffected by the S727 mutation, because
ERK-1/2 activation in response to CpG DNA was comparable be-
tween WT and STAT1S727A BMM (Fig. 6B).
Given that CpG DNA activated the type I IFN pathway in DC,
but not macrophages (Fig. 1), we predicted that STAT1, phosphor-
ylated on S727, but not Y701, would have a unique function in
macrophages. This was examined by comparing the expression of
known CpG DNA-responsive genes in BMM from WT and
STAT1S727A mutant animals. Induction of both Il-12p40 and
Cox-2 mRNAs was enhanced 3- to 4-fold in BMM from the mu-
tant mice (Fig. 7, A and B), whereas the induction of Il-6 and Tnf
mRNA by CpG DNA was unaffected (Fig. 7, C and D). CpG DNA
also selectively represses expression of some genes, including cer-
tain receptors and signal transducers. Both Tlr4 and Tlr9 mRNAs
were transiently repressed by CpG DNA in WT BMM, and were
hyperrepressed in STAT1S727A BMM (Fig. 7, E and F). Hence,
phosphorylation of STAT1 at S727 constrains both the induction
(Il-12p40, Cox-2) and the repression (Tlr4, Tlr9) of certain genes
in response to CpG DNA. The data therefore support a regulatory
FIGURE 6. CpG DNA-induced ERK phosphorylation is intact in
STAT1S727A BMM. A, BMM from WT and STAT1S727A mice were stim-
ulated with CpG DNA over a 2-h time course in matched samples. Levels
of phospho-S727 STAT1 (p-S727), phospho-Y701 STAT1 (p-Y701), and
total STAT1 in whole cell extracts were detected by immunoblotting. A
positive control for Y701 STAT1 phosphorylation (C, 0.5-h IFN- stim-
ulation) was included in the time course. B, BMM from WT and
STAT1S727A mice were stimulated with CpG DNA over a 7-h time course
in matched samples. Cells were also treated with the GpC DNA-negative
control oligonucleotide (C, 0.25-h GpC DNA). Levels of phospho-ERK-
1/2 (p-ERK) and total ERK-1/2 were determined by immunoblotting.
FIGURE 7. CpG DNA-modulated
gene expression is selectively dysregu-
lated in STAT1S727A BMM. BMM
from WT () and STAT1S727A mice
(f) were stimulated with CpG DNA
over a 21-h time course. Total cellular
RNA from matched samples was ex-
tracted, and mRNAs for Il-12p40 (A),
Cox-2 (B), Il-6 (C), Tnf (D), Tlr4 (E),
and Tlr9 (F) were measured by quanti-
tative PCR. Expression is shown as fold
induction over basal expression within
the genotype. Profiles are representa-
tive of three independent experiments.
3500 DIVERGENT MACROPHAGE AND DC RESPONSES TO CpG DNA
 by guest on January 22, 2014
http://w
w
w
.jimmunol.org/
D
ow
nloaded from
 
role for serine-phosphorylated STAT1 in limiting macrophage re-
sponses to CpG DNA.
A TLR7 agonist triggers alternative STAT1 activation in primary
human monocyte-derived macrophages (HMDM)
It is generally accepted that human monocytes do not respond to
CpG DNA, which might imply that STAT1 cannot be alternatively
activated in human monocytes or macrophages. We hypothesized,
however, that any TLR agonist that activates the p38 MAPK path-
way without concomitant induction of autocrine IFN- signaling
would initiate alternative STAT1 activation in human macro-
phages. We therefore examined the activation of this pathway in
response to the TLR7 agonist, R837 (imiquimod) (27, 28), in
HMDM. Although LPS strongly induced Ifn- mRNA as ex-
pected, R837 was ineffective at inducing Ifn- mRNA (Fig. 8A) or
the IFN- target gene Ip-10 (Fig. 8B) in HMDM. In contrast, this
signal triggered robust Il-1 mRNA expression (330-fold, Fig. 8C)
and p38 MAPK phosphorylation (Fig. 8D). Consistent with the
ability of R837 to activate p38 MAPK, but not IFN- signaling
(Fig. 8, A, B, and D), R837 elicited alternative STAT1 activation
(monophosphorylation at S727), whereas LPS triggered classical
STAT1 activation (S727 and Y701 phosphorylation) in HMDM
(Fig. 8D). Thus, alternative and classical STAT1 activation occur
in both mouse and human primary macrophages.
Discussion
Although Ifn- was initially identified as a MyD88-independent
target gene in TLR3 and TLR4 signaling pathways in macro-
phages, CpG DNA induces this gene in a MyD88-dependent fash-
ion in pDC (25, 26) and myeloid DC (23, 24). We confirmed that
myeloid DC and macrophages are different in this respect; CpG
DNA induced Ifn- mRNA expression as well as IFN- target
genes in a MyD88-dependent fashion only in BMDC (Figs. 1 and
2) (23, 24). Although A-type oligonucleotides such as D19 and
1585 are reportedly a much more powerful stimulus for type I IFN
production than B-type oligonucleotides in pDC (26, 37), we
found that BMDC responded robustly to the B-type oligonucleo-
tide 1668S in this respect (Fig. 1), consistent with the recent find-
ings of Schmitz et al. (23). This pathway was important for my-
eloid DC maturation and function, because maximal TNF and IL-6
production and costimulatory molecule expression in response to
CpG DNA were dependent upon autocrine IFN signaling (Fig. 3).
In macrophages, even A-type oligonucleotides were ineffective
at inducing Ifn- mRNA expression (Fig. 1H) and downstream
IFN target genes (Fig. 1I). The endosomal trafficking of A-type
oligonucleotides leading to IRF7-dependent induction of type I
IFN (26) is likely to be unique to the antiviral function of pDC.
The use of the autocrine type I IFN pathway in DC, but not mac-
rophages, may contribute to the enhanced capacity of DC to act as
professional APC, and implies that endogenous IFN contributes to
functional divergence between macrophages and myeloid DC. The
differential responses of DC and macrophages to CpG DNA are
summarized in Fig. 9.
FIGURE 8. R837 triggers S727, but not
Y701, STAT1 phosphorylation in HMDM.
HMDM were treated with 10 g/ml R837 or
10 ng/ml LPS for 2 h. A–C, Total cellular
RNA was prepared, and mRNA expression of
Ifn- (A), Ip-10 (B), and Il-1 (C) relative to
Hprt was determined by qPCR. Data points
represent the average of triplicates  SD. D,
Phospho-S727 STAT1 (p-S727), phospho-
Y701 STAT1 (p-Y701), total STAT1, phos-
pho-p38 MAPK (p-p38), and total p38 MAPK
in whole cell extracts were detected by immu-
noblotting. RNA and protein profiles are in-
dicative of duplicate experiments from inde-
pendent blood donors.
FIGURE 9. Model for divergent STAT1 activation and function in re-
sponse to CpG DNA in DC vs macrophages. CpG DNA stimulation of DC
causes STAT1 phosphorylation at both the S727 and Y701 residues. S727
phosphorylation occurs rapidly (within 30 min) and is mediated by a p38
MAPK-dependent pathway. Y701 phosphorylation occurs in a delayed
fashion (2 h), and is mediated by the autocrine activity of CpG DNA-
induced IFN-. Y701/S727-double phosphorylated STAT1 dimerizes and
translocates to the nucleus to trans activate classic STAT1 target genes
such as Ip-10 and to induce costimulatory molecule expression and proin-
flammatory cytokine production. CpG DNA stimulation of macrophages
triggers phosphorylation of STAT1 at the S727 residue only. In contrast to
DC, CpG DNA does not induce the production and autocrine activities of
IFN- in macrophages, and so STAT1 remains in the Y701-unphosphor-
ylated form that cannot dimerize or translocate to the nucleus. Cytoplasmic
STAT1 indirectly modulates gene expression (e.g., Tlr4, Tlr9, Cox-2, Il-
12p40), perhaps by cytoplasmic sequestration of gene regulatory factors.
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The mechanisms responsible for the divergent effects of CpG
DNA on IFN- expression in DC vs macrophages may be linked
to differential expression or function of the IRF transcription factor
family. The induction of IFN- by CpG DNA requires IRF7 in
pDC (25, 26) and IRF1 in BMDC (23, 24). In BMM, IFN- in-
duced IRF1 mRNA expression and enabled the assembly of the
MyD88-dependent pathway leading to IFN- production in re-
sponse to CpG DNA (23). Thus, a likely explanation is that either
IRF1 expression or function is limiting in resting macrophages.
However, differential expression of other IRF family members
might also explain the absence of the MyD88-IFN- pathway in
this cell type. We recently showed that the mRNA expression of
IRF4, as well as IRF8 that has been implicated in CpG DNA-
specific signaling in DC (44), was down-regulated by the macro-
phage growth factor, CSF-1, in BMM (34). A prediction of this
finding is that these factors would be more highly expressed in DC
than in macrophages. Certainly, IRF4 and IRF8 are functionally
required for DC differentiation in response to GM-CSF and FLT-3,
respectively (45). We are currently characterizing the expression
of the entire IRF family in macrophages vs BMDC to identify
differentially expressed family members.
Although CpG DNA did not activate the classical type I IFN-
dependent pathway in BMM, the phosphorylation of STAT1 on
S727 (Fig. 4) led to an alternative activation state in which STAT1
was retained in the cytoplasm (Fig. 5). Gene expression profiles
comparing WT and S727A STAT1 mutant macrophages (Fig. 7)
suggest that phosphorylation on this amino acid contributes to
CpG DNA-mediated signaling in macrophages. Serine phosphor-
ylation of STAT1 regulates interactions with several binding part-
ners (e.g., BRCA1, CBP, MCM5 (12, 46–48)). On this basis, we
propose that S727-phosphorylated STAT1 functions to sequester
transcriptional regulators in the cytoplasm of CpG DNA-stimu-
lated macrophages. Such a mechanism was demonstrated in os-
teoblasts, where serine-phosphorylated STAT1 sequestered the
RUNX2 transcription factor in the cytoplasm in an inducible man-
ner that was independent of Y701 phosphorylation (49).
One possibility is that members of the IRF family could be
targeted for cytoplasmic sequestration by S727-phosphorylated
STAT1 in macrophages. For example, IRF9, which normally re-
sides in both the nucleus and cytoplasm, was retained in the cy-
toplasm when coexpressed with STAT2 (50). The IRF9 nuclear
localization signal is contained within the DNA binding domain
and is conserved in IRF8 and IRF4 (50), and it is possible that
these IRFs could be inducibly retained by STAT1 in the cytoplasm
of macrophages, upon S727 phosphorylation. In support of such a
mechanism, IRF8 was reported to bind to nontyrosine-phos-
phorylated STAT1 (51). Other IRF family members are also
candidates. IRF1, which was reported to interact with STAT1
(17), positively regulated the inducible expression of Cox-2
(52) and Il-12-p40 (53), both of which were superinduced by
CpG DNA in STAT1S727A BMM (Fig. 7). Similarly, IRF2,
which can also form a complex with STAT1 (54), was impli-
cated in driving IL-12p40 expression (53). STAT1S727A BMM
may therefore permit the nuclear translocation of one or more
IRF family members and the superinduction of Cox-2, Il-12-
p40, and coregulated genes in response to CpG DNA; we are
currently investigating this hypothesis.
The differing activity profiles of STAT1 in response to CpG
DNA and LPS may underpin their very different toxicities. IFN-
signaling and classic STAT1 trans-activator function in macro-
phages contributes to LPS-mediated toxicity in vivo (55, 56). CpG
DNA is less toxic than LPS in vivo, and the apparently anti-
inflammatory actions of alternatively activated STAT1 may be
protective in this context.
Alternative STAT1 activation was not just restricted to CpG
DNA signaling in mouse macrophages. The TLR7 agonist, R837,
induced a similar activation profile (monophosphorylation at
S727) due to a failure of autocrine IFN- signaling in HMDM
(Fig. 8). It is likely that a range of stimuli that activate the p38
MAPK pathway without inducing autocrine IFN signaling trigger
alternative STAT1 activation. Furthermore, this pathway may also
operate as a feedback regulator of TLR4 signaling because LPS
triggers sustained S727 phosphorylation, but transient Y701 phos-
phorylation (Fig. 4). That is, a shift from classical to alternative
STAT1 function after prolonged activation via TLR4 may act to
sequester transcriptional activators in the cytoplasm.
In summary, we propose that the IFN-/STAT1 axis is a key
regulator of CpG DNA signaling, and that divergent activation of
this pathway between macrophages and DC dictates cell-specific
responses to CpG DNA. CpG DNA induces autocrine IFN- sig-
naling and classic STAT1 transcription factor activities in myeloid
DC, thereby potentiating expression of IFN-target genes, costimu-
latory molecules (CD80 and CD86), and proinflammatory cyto-
kines (IL-6, TNF). The lack of this autocrine pathway in CpG
DNA-stimulated macrophages enables alternative STAT1 activi-
ties that may include sequestration of gene regulatory factors to
limit CpG DNA responses. This blockade could be overcome by
IFN-, which can induce STAT1 Y701 phosphorylation and nu-
clear translocation. In such a scenario, STAT1 would be rapidly
transformed from signaling repressor to transcriptional activator to
elicit appropriate antimicrobial responses.
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